Department of Bioengineering, Nagaoka University of Technology, Nagaoka, Niigata, 940-2188, Japan.
Department of Applied Chemistry and Biochemistry, National Institute of Technology, Fukushima College, Iwaki, Fukushima, 970-8034, Japan.
Appl Microbiol Biotechnol. 2022 Apr;106(7):2651-2663. doi: 10.1007/s00253-022-11870-w. Epub 2022 Mar 19.
D-Aspartate (D-Asp) is a useful compound for a semisynthetic antibiotic and has potentially beneficial effects on humans. Several lactic acid bacteria (LAB) species produce D-Asp as a component of cell wall peptidoglycan. We previously isolated a LAB strain (named strain WDN19) that can extracellularly produce a large amount of D-Asp. Here, we show the factors that contribute to high D-Asp production ability. Strain WDN19 was most closely related to Latilactobacillus curvatus. The D-Asp production ability of strain WDN19 in a rich medium was 13.7-fold higher than that of L. curvatus DSM 20019. A major part of D-Asp was synthesized from L-Asp contained in the medium by aspartate racemase (RacD). During their cultivation, the RacD activity in strain WDN19 was higher than in strain DSM 20019, especially much higher in the early exponential growth phase because of the higher racD transcription and the higher activity of RacD itself of strain WDN19. In a synthetic medium, the extracellular production of D,L-Asp was observed in strain WDN19 but not in strain DSM 20019. The addition of L-asparagine (L-Asn) to the medium increased and gave D,L-Asp production in strains WDN19 and DSM 20019, respectively, suggesting L-Asp synthesis by L-asparaginase (AsnA). The L-Asn uptake ability of the strains was similar, but the AsnA activity in the middle exponential and early stationary growth phases and intracellular D,L-Asp was much higher in strain WDN19. In their genome sequences, only an aspartate aminotransferase gene was found among L-Asp-metabolizing enzymes, except for RacD, but was disrupted in strain WDN19 by transposon insertion. These observations indicated that the high D-Asp production ability of strain WDN19 was mainly based on high RacD and AnsA activities and L-Asp supply. KEY POINTS: • Strain WDN19 was suggested to be a strain of Latilactobacillus curvatus. • Extracellular high d-Asp production ability was not a common feature of L. curvatus. • High d-Asp production was due to high RacD and AnsA activities and l-Asp supply.
D-天冬氨酸(D-Asp)是一种有用的半合成抗生素化合物,对人类具有潜在的有益作用。几种乳杆菌(LAB)物种产生 D-Asp 作为细胞壁肽聚糖的组成部分。我们之前分离出一种能够细胞外大量产生 D-Asp 的 LAB 菌株(命名为 WDN19 菌株)。在这里,我们展示了导致高 D-Asp 产生能力的因素。WDN19 菌株与拉氏乳杆菌(Latilactobacillus curvatus)最为密切相关。在丰富培养基中,WDN19 菌株的 D-Asp 产生能力比 L. curvatus DSM 20019 高 13.7 倍。D-Asp 的主要部分是由培养基中包含的 L-天冬氨酸通过天冬氨酸外消旋酶(RacD)合成的。在培养过程中,WDN19 菌株的 RacD 活性高于 DSM 20019 菌株,尤其是在早期指数生长阶段更高,因为 WDN19 菌株的 racD 转录更高,RacD 本身的活性也更高。在合成培养基中,观察到 WDN19 菌株中外源产生 D,L-天冬氨酸,但 DSM 20019 菌株中没有。向培养基中添加 L-天冬酰胺(L-Asn)分别增加了 WDN19 菌株和 DSM 20019 菌株的 D,L-天冬氨酸产量,表明通过天冬酰胺酶(AsnA)合成 L-天冬氨酸。菌株的 L-天冬酰胺摄取能力相似,但在中指数和早期静止生长阶段,WDN19 菌株的 AsnA 活性和细胞内 D,L-天冬氨酸更高。在它们的基因组序列中,除了 RacD 之外,在 L-天冬氨酸代谢酶中只发现了一个天冬氨酸氨基转移酶基因,但在 WDN19 菌株中被转座子插入破坏。这些观察结果表明,WDN19 菌株的高 D-Asp 产生能力主要基于高 RacD 和 AnsA 活性和 L-Asp 供应。关键点:• WDN19 菌株被建议为拉氏乳杆菌(Latilactobacillus curvatus)的一个菌株。• 细胞外高 D-Asp 产生能力不是 L. curvatus 的共同特征。• 高 D-Asp 产生是由于 RacD 和 AnsA 活性高和 L-Asp 供应充足。